Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 84 (4) , 417-424
- https://doi.org/10.1016/s1081-1206(10)62275-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Glucocorticoids Inhibit Proliferation and Interleukin-4 and Interleukin-5 Secretion by Aeroallergen-Specific T-Helper Type 2 Cell LinesAnnals of Allergy, Asthma & Immunology, 1998
- A Controlled Trial of Twice Daily Triamcinolone Oral Inhaler in Patients with Mild-to-Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthmaJournal of Allergy and Clinical Immunology, 1998
- Clinical aspects of allergic diseaseJournal of Allergy and Clinical Immunology, 1998
- Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?Annals of Allergy, Asthma & Immunology, 1997
- Glucocorticosteroids Inhibit Leukotriene ProductionAnnals of Allergy, Asthma & Immunology, 1997
- Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1997
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis PatientsAnnals of Allergy, Asthma & Immunology, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992